Drugs / TYLOXAPOL
TYLOXAPOL
also known as
Alevaire · NSC-90255 · Superinone · Tacholiquine · Tiloxapol · Tyloxapol component of exosurf neonatal
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02515799 Comparator | Aug 2014 → Jan 2015 | chronic bronchitis | bene-Arzneimittel GmbH | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TYLOXAPOL | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Known as | Alevaire | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Known as | NSC-90255 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Known as | Superinone | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Known as | Tacholiquine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02515799 ↗ |
| Known as | Tiloxapol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Known as | Tyloxapol component of exosurf neonatal | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201548 ↗ |
| Route | Inhaled | “Inhaled Tacholiquine ®1% - 5ml” NCT02515799 ↗ |